Cargando…
Fenofibrate alleviates insulin resistance by reducing tissue inflammation in obese ovariectomized mice
BACKGROUND: Fenofibrate is a hypolipidemic peroxisome proliferator-activated receptor α (PPARα) agonist used clinically to reduce hypercholesterolemia and hypertriglyceridemia. OBJECTIVE: We investigated the effects of fenofibrate on insulin resistance and tissue inflammation in a high-fat diet (HFD...
Autores principales: | Lee, Jungu, Jeon, Suyeon, Lee, Mijeong, Yoon, Michung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630285/ https://www.ncbi.nlm.nih.gov/pubmed/37935669 http://dx.doi.org/10.1038/s41387-023-00249-z |
Ejemplares similares
-
Fenofibrate Regulates Visceral Obesity and Nonalcoholic Steatohepatitis in Obese Female Ovariectomized C57BL/6J Mice
por: Shin, Yujin, et al.
Publicado: (2021) -
Scutellaria baicalensis Alleviates Insulin Resistance in Diet-Induced Obese Mice by Modulating Inflammation
por: Na, Hyun-Young, et al.
Publicado: (2019) -
Resveratrol alleviates obesity-associated podocyte injury in ovariectomized obese rats
por: Li, Bing, et al.
Publicado: (2020) -
PPARα in Obesity: Sex Difference and Estrogen Involvement
por: Yoon, Michung
Publicado: (2010) -
Reducing Glycosphingolipid Content in Adipose Tissue of Obese Mice Restores Insulin Sensitivity, Adipogenesis and Reduces Inflammation
por: van Eijk, Marco, et al.
Publicado: (2009)